126 related articles for article (PubMed ID: 35437860)
21. Synthesis and biological evaluation of cholecystokinin analogs in which the Asp-Phe-NH2 moiety has been replaced by a 3-amino-7-phenylheptanoic acid or a 3-amino-6-(phenyloxy)hexanoic acid.
Amblard M; Rodriguez M; Lignon MF; Galas MC; Bernad N; Artis-Noël AM; Hauad L; Laur J; Califano JC; Aumelas A
J Med Chem; 1993 Oct; 36(20):3021-8. PubMed ID: 7692048
[TBL] [Abstract][Full Text] [Related]
22. Partial amino acid sequence of human plasma retinol-binding protein. Isolation and alignment of the five cyanogen bromide fragments and the amino acid sequences of four of the fragments.
Kanda Y; Goodman DS
J Lipid Res; 1979 Sep; 20(7):865-78. PubMed ID: 573775
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory effects of the novel platelet activating factor receptor antagonist, 1-ethyl-2-[N-(2-methoxy)benzoyl-N-[(2R)-2-methoxy-3-(4- octadecylcarbamoyloxy) piperidinocarbonyloxypropyloxy]carbonyl] aminomethyl-pyridinium chloride, in several experimentally induced shock models.
Nagaoka J; Harada K; Kimura A; Kobayashi S; Murakami M; Yoshimura T; Yamada K; Asano O; Katayama K; Yamatsu I
Arzneimittelforschung; 1991 Jul; 41(7):719-24. PubMed ID: 1663352
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of platelet function with synthetic peptides designed to be high-affinity antagonists of fibrinogen binding to platelets.
Ruggeri ZM; Houghten RA; Russell SR; Zimmerman TS
Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5708-12. PubMed ID: 3016716
[TBL] [Abstract][Full Text] [Related]
25. Effect of the PAF-antagonist WEB 2086 on anaphylactic lung reaction: comparison of inhalative and intravenous challenge.
Heuer H; Casals-Stenzel J
Agents Actions Suppl; 1988; 23():207-15. PubMed ID: 3262991
[TBL] [Abstract][Full Text] [Related]
26. Effect of human plasma-type platelet-activating factor acetylhydrolase in two anaphylactic shock models.
Fukuda Y; Kawashima H; Saito K; Inomata N; Matsui M; Nakanishi T
Eur J Pharmacol; 2000 Feb; 390(1-2):203-7. PubMed ID: 10708725
[TBL] [Abstract][Full Text] [Related]
27. [Changes of prostaglandin D2,carboxypeptidase A3 and platelet activating factor in guinea pig in anaphylactic shock].
Yang K; Guo XJ; Yan XB; Gao CR
Fa Yi Xue Za Zhi; 2012 Jun; 28(3):175-8. PubMed ID: 22812216
[TBL] [Abstract][Full Text] [Related]
28. Primary structure of murine major histocompatibility complex alloantigens. Amino acid sequence of the NH2-terminal ninety-eight residues of the H-2Db glycoprotein.
Maloy WL; Nathenson SG; Coligan JE
J Biol Chem; 1981 Mar; 256(6):2863-72. PubMed ID: 7225204
[TBL] [Abstract][Full Text] [Related]
29. PAF, rather than histamine, participates in mouse anaphylactic hypotension.
Shibamoto T; Liu W; Cui S; Zhang W; Takano H; Kurata Y
Pharmacology; 2008; 82(2):114-20. PubMed ID: 18583921
[TBL] [Abstract][Full Text] [Related]
30. Mouse anaphylactic shock is caused by reduced cardiac output, but not by systemic vasodilatation or pulmonary vasoconstriction, via PAF and histamine.
Wang M; Shibamoto T; Tanida M; Kuda Y; Kurata Y
Life Sci; 2014 Oct; 116(2):98-105. PubMed ID: 25252221
[TBL] [Abstract][Full Text] [Related]
31. Effect of the hetrazepinoic platelet-activating factor antagonist Bepafant (WEB 2170) in models of active and passive anaphylaxis in mice and guinea pigs.
Heuer HO
Lipids; 1991 Dec; 26(12):1374-80. PubMed ID: 1819736
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and activity of a cyclo-heptapeptide containing Lys-Gly-Asp-sequence as a novel anti-platelet agent.
Jing J
Bioorg Khim; 2013; 39(5):547-51. PubMed ID: 25702411
[TBL] [Abstract][Full Text] [Related]
33. The primary structure of iron-superoxide dismutase from Photobacterium leiognathi.
Barra D; Schininà ME; Bannister WH; Bannister JV; Bossa F
J Biol Chem; 1987 Jan; 262(3):1001-9. PubMed ID: 3542995
[TBL] [Abstract][Full Text] [Related]
34. Platelet-activating factor in the inflammatory exudate in the anaphylactic phase of allergic inflammation in rats.
Watanabe M; Ohuchi K; Sugidachi A; Hirasawa N; Hayashi Y; Tsurufuji S
Int Arch Allergy Appl Immunol; 1987; 84(4):396-403. PubMed ID: 3119503
[TBL] [Abstract][Full Text] [Related]
35. Involvement of platelet-activating factor in death following anaphylactic shock in boosted and in unboosted mice.
Amorim CZ; Cordeiro RS; Vargaftig BB
Eur J Pharmacol; 1993 Apr; 235(1):17-22. PubMed ID: 8519279
[TBL] [Abstract][Full Text] [Related]
36. Tachykinins and other biologically active peptides from the skin of the Costa Rican phyllomedusid frog Agalychnis callidryas.
Mignogna G; Severini C; Erspamer GF; Siciliano R; Kreil G; Barra D
Peptides; 1997; 18(3):367-72. PubMed ID: 9145422
[TBL] [Abstract][Full Text] [Related]
37. Amino acid sequence of bovine brain derived class 1 heparin-binding growth factor.
Strydom DJ; Harper JW; Lobb RR
Biochemistry; 1986 Mar; 25(5):945-51. PubMed ID: 2421762
[TBL] [Abstract][Full Text] [Related]
38. Aqueous ethanol extract of the fruit of Xylopia aethiopica (Annonaceae) exhibits anti-anaphylactic and anti-inflammatory actions in mice.
Obiri DD; Osafo N
J Ethnopharmacol; 2013 Jul; 148(3):940-5. PubMed ID: 23747538
[TBL] [Abstract][Full Text] [Related]
39. Discovery and structure--activity relationship studies of a novel and specific peptide motif, Pro-X-X-X-Asp-X, as a platelet fibrinogen receptor antagonist.
Hayashi Y; Katada J; Sato Y; Igarashi K; Takiguchi Y; Harada T; Muramatsu M; Yasuda E; Uno I
Bioorg Med Chem; 1998 Mar; 6(3):355-64. PubMed ID: 9568289
[TBL] [Abstract][Full Text] [Related]
40. Detailed characterization of an anti-factor IX monoclonal antibody that neutralizes the prolonged ox brain prothrombin time of hemophilia B(M) by synthetic peptides.
Takahashi I; Kojima T; Sano M; Watanabe T; Kamiya T; Saito H
Peptides; 2000 May; 21(5):603-8. PubMed ID: 10876041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
